These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 12007524)

  • 21. IPD-1151T (suplatast tosilate) inhibits interleukin (IL)-13 release but not IL-4 release from basophils.
    Shichijo M; Shimizu Y; Hiramatsu K; Togawa M; Inagaki N; Takagi K; Nagai H
    Jpn J Pharmacol; 1999 Apr; 79(4):501-4. PubMed ID: 10361893
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective enhancement of production of IgE, IgG4, and Th2-cell cytokine during the rebound phenomenon in atopic dermatitis and prevention by suplatast tosilate.
    Kimata H
    Ann Allergy Asthma Immunol; 1999 Mar; 82(3):293-5. PubMed ID: 10094221
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Afferent nerve regulation of bladder function in health and disease.
    de Groat WC; Yoshimura N
    Handb Exp Pharmacol; 2009; (194):91-138. PubMed ID: 19655106
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suplatast tosilate dimethylsulfonium treatment for steroid-dependent nephrotic syndrome.
    Ohtomo Y; Fujinaga S; Hattori M
    Pediatr Int; 2005 Apr; 47(2):230-1. PubMed ID: 15771702
    [No Abstract]   [Full Text] [Related]  

  • 25. Suplatast tosilate affects the initial increase in specific IgE and interleukin-4 during immunotherapy for perennial allergic rhinitis.
    Washio Y; Ohashi Y; Tanaka A; Kakinoki Y; Sugiura Y; Sakamoto H; Yamada K; Matsuda M; Uekawa M; Okamoto H; Nakai Y
    Acta Otolaryngol Suppl; 1998; 538():126-32. PubMed ID: 9879412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Suppressive effects of IPD-1151T (suplatast-tosilate) on induction of mast cells from normal mouse splenocytes.
    Konno S; Adachi M; Asano K; Gonogami Y; Ikeda K; Okamoto K; Takahashi T
    Eur J Pharmacol; 1994 Jun; 259(1):15-20. PubMed ID: 7957588
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of non-episodic angioedema associated with eosinophilia with suplatast tosilate, an anti-allergic selective Th2 cytokine inhibitor.
    Hashizume H; Umayahara T
    Eur J Dermatol; 2014; 24(2):250-2. PubMed ID: 24723649
    [No Abstract]   [Full Text] [Related]  

  • 28. [Inhibitory effect of suplatast tosilate on eosinophil migration].
    Kobayashi Y; Nagata M; Yamamoto H; Sakamoto Y
    Arerugi; 2000 Jul; 49(7):600-3. PubMed ID: 10944827
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suppressive effects of anti-allergic agent suplatast tosilate (IPD-1151T) on the expression of co-stimulatory molecules on mouse splenocytes in vivo.
    Kurokawa M; Kawazu K; Asano K; Fumio K; Mita A; Adachi M
    Mediators Inflamm; 2001 Dec; 10(6):333-7. PubMed ID: 11817674
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cough-variant asthma successfully treated with suplatast tosilate].
    Fujimori K; Suzuki E; Arakawa M
    Arerugi; 1998 Jul; 47(7):694-7. PubMed ID: 9780445
    [No Abstract]   [Full Text] [Related]  

  • 31. Pemphigoid nodularis associated with psoriatic erythroderma: successful treatment with suplatast tosilate.
    Teraki Y; Fukuda T
    Br J Dermatol; 2008 Feb; 158(2):424-6. PubMed ID: 18047503
    [No Abstract]   [Full Text] [Related]  

  • 32. Tetrodotoxin-resistant sodium channels Na(v)1.8/SNS and Na(v)1.9/NaN in afferent neurons innervating urinary bladder in control and spinal cord injured rats.
    Black JA; Cummins TR; Yoshimura N; de Groat WC; Waxman SG
    Brain Res; 2003 Feb; 963(1-2):132-8. PubMed ID: 12560118
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Chronic eosinophilic pneumonia successfully treated with suplatast tosilate].
    Hamada H; Sakatani M; Nishioka M; Akira M; Yamamoto S; Ueda E; Okano Y; Nakamura Y; Sone S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Jun; 35(6):692-7. PubMed ID: 9294307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibitory effects of suplatast tosilate on the differentiation and function of monocyte-derived dendritic cells from patients with asthma.
    Tanaka A; Minoguchi K; Samson KT; Oda N; Yokoe T; Tazaki T; Yamamoto Y; Yamamoto M; Ohta S; Adachi M
    Clin Exp Allergy; 2007 Jul; 37(7):1083-9. PubMed ID: 17581203
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful treatment of pediatric hypereosinophilic syndrome with suplatast tosilate.
    Yamada Y; Yoshihara S; Arisaka O
    Ann Allergy Asthma Immunol; 2007 Oct; 99(4):380-1. PubMed ID: 17941289
    [No Abstract]   [Full Text] [Related]  

  • 36. Kimura's disease treated with suplatast tosilate and loratadine.
    Ueda T; Arai S; Amoh Y; Katsuoka K
    Eur J Dermatol; 2011; 21(6):1020-1. PubMed ID: 21914581
    [No Abstract]   [Full Text] [Related]  

  • 37. [Case of interstitial cystitis accompanied by food allergy].
    Ogawa H; Nakamura Y; Tokinaga K; Sakakura N; Yamashita M
    Arerugi; 2005 Jul; 54(7):641-5. PubMed ID: 16229364
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A case of recurrent cutaneous eosinophilic vasculitis: successful adjuvant therapy with suplatast tosilate.
    Sakuma-Oyama Y; Nishibu A; Oyama N; Saito M; Nakamura K; Kaneko F
    Br J Dermatol; 2003 Oct; 149(4):901-3. PubMed ID: 14616398
    [No Abstract]   [Full Text] [Related]  

  • 39. Suplatast tosilate alleviates nasal symptoms through the suppression of nuclear factor of activated T-cells-mediated IL-9 gene expression in toluene-2,4-diisocyanate-sensitized rats.
    Mizuguchi H; Orimoto N; Kadota T; Kominami T; Das AK; Sawada A; Tamada M; Miyagi K; Adachi T; Matsumoto M; Kosaka T; Kitamura Y; Takeda N; Fukui H
    J Pharmacol Sci; 2016 Mar; 130(3):151-8. PubMed ID: 26874672
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-inflammatory effect of suplatast tosilate on mild asthma.
    Sano Y; Miyamoto T; Makino S
    Chest; 1997 Sep; 112(3):862-3. PubMed ID: 9315837
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.